diabetes body type ????treatment and ... - megaroll.info
We introduced GM to all seven of our health system's ICUs. The intravenous GM software licensed by Glytec was used, and the multiplier used at our institution is 0.01. This multiplier has been selected based on previous evidence suggesting improved treatment outcomes when selecting a multiplier of 0.01 in the management of DKA [6].
Get Price